SURROZEN INC (SRZN) Forecast, Price Target & Analyst Ratings
NASDAQ:SRZN • US86889P2083
25.9 USD
-1.05 (-3.91%)
At close: Mar 12, 2026
25.8783 USD
-0.02 (-0.08%)
After Hours: 3/12/2026, 8:11:46 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SURROZEN INC (SRZN).
Forecast Snapshot
Consensus Price Target
$42.84
+ 65.41% Upside
Next Earnings Forecast
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$1.21
Revenue Estimate674.22K
ChartMill Buy Consensus
84.44%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$42.84
Upside
+ 65.41%
From current price of $25.90 to mean target of $42.84, Based on 9 analyst forecasts
Low
$42.42
Median
$42.84
High
$44.10
Price Target Revisions
1 Month
0.00%
3 Months
13.51%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for SRZN. The average price target is 42.84 USD. This implies a price increase of 65.41% is expected in the next year compared to the current price of 25.9.
The average price target has been revised upward by 13.51% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
SRZN was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SRZN.
In the previous month the buy percentage consensus was at a similar level.
SRZN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-01-03 | Guggenheim | Upgrade | Neutral -> Buy |
| 2022-11-29 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-11-18 | Guggenheim | Downgrade | Buy -> Neutral |
| 2022-11-17 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2022-10-17 | JP Morgan | Initiate | Neutral |
| 2022-05-27 | B of A Securities | Downgrade | Buy -> Neutral |
| 2021-10-11 | B of A Securities | Initiate | Buy |
| 2021-09-15 | Guggenheim | Initiate | Buy |
| 2021-09-07 | Stifel | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$1.21
Revenue Estimate674.22K
Revenue Q2Q2.93%
EPS Q2Q86.70%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
32.20%
Revenue (3 Months)
32.20%
EPS (1 Month)
-2.30%
EPS (3 Months)
-2.30%
Next Earnings Summary
SRZN is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -1.21 USD and the consensus revenue estimate is 674.22K USD.
The next earnings revenue estimate has been revised upward by 32.2% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.5M | -100.00% | 10.655M | 3.666M -65.59% | 1.337M -63.53% | 1.337M | -100.00% | 1.337M | 6.107M 356.77% | 25.477M 317.18% | 48.181M 89.12% | 126.05M 161.62% | |
| EBITDA YoY % growth | -42.38M 19.00% | -40.817M 3.69% | -24.097M 40.96% | -56.1M -132.81% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -44.34M 18.48% | -42.728M 3.64% | -25.539M 40.23% | -41.585M -62.83% | -51.762M -24.47% | -69.499M -34.27% | -85.541M -23.08% | -111.918M -30.84% | -138.716M -23.94% | -146.008M -5.26% | -104.415M 28.49% | -51.875M 50.32% | |
| Operating Margin | -354.72% | N/A | -239.69% | -1,134.35% | -3,871.50% | -5,198.11% | N/A | -8,370.84% | -2,271.42% | -573.10% | -216.71% | -41.15% | |
| EPS YoY % growth | -15.60 58.10% | -21.36 -36.92% | -15.32 28.28% | -9.56 37.58% | -4.52 52.78% | -3.88 14.16% | -5.52 -42.37% | -5.21 5.55% | -5.36 -2.74% | -3.81 28.76% | -1.47 61.50% | 0.94 163.89% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.21 86.70% | -1.33 82.11% | -1.28 -150.00% | -0.96 88.53% | -0.97 19.94% |
| Revenue Q2Q % growth | 674.22K 2.93% | 334.223K | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.582M -34.80% | -12.545M -31.35% | -12.632M -40.09% | -13.105M -20.40% | -13.697M -18.26% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.44%
EPS Next 5 Year
10.66%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-36.00%
Revenue Next 5 Year
-23.49%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SURROZEN INC / SRZN Forecast FAQ
What is the average price target for SURROZEN INC (SRZN) stock?
9 analysts have analysed SRZN and the average price target is 42.84 USD. This implies a price increase of 65.41% is expected in the next year compared to the current price of 25.9.
When does SURROZEN INC (SRZN) report earnings?
SURROZEN INC (SRZN) will report earnings on 2026-03-30, after the market close.
Can you provide the consensus estimates for SURROZEN INC next earnings?
The consensus EPS estimate for the next earnings of SURROZEN INC (SRZN) is -1.21 USD and the consensus revenue estimate is 674.22K USD.
What is the expected long term growth rate for SRZN stock?
The expected long term growth rate for SURROZEN INC (SRZN) is -36%.